|
WO1988006371A1
(fr)
|
1987-02-13 |
1988-08-25 |
Mitsubishi Denki Kabushiki Kaisha |
Demarreur/chargeur pour moteurs
|
|
US5112824A
(en)
|
1989-12-08 |
1992-05-12 |
Merck & Co., Inc. |
Benzofuran compounds as class III antiarrhythmic agents
|
|
US5498711A
(en)
|
1993-02-03 |
1996-03-12 |
Thiokol Corporation |
Synthesis of 4,10-dinitro-2,6,8,12-tetraoxa-4,10-diazatetracyclo[5.5.0.05,903,11]dodecane
|
|
US5474995A
(en)
|
1993-06-24 |
1995-12-12 |
Merck Frosst Canada, Inc. |
Phenyl heterocycles as cox-2 inhibitors
|
|
US5466823A
(en)
|
1993-11-30 |
1995-11-14 |
G.D. Searle & Co. |
Substituted pyrazolyl benzenesulfonamides
|
|
BR9607035A
(pt)
|
1995-02-13 |
1997-11-04 |
Searle & Co |
Isoxazois substituidos para o tratamento de inflamação
|
|
US5633272A
(en)
|
1995-02-13 |
1997-05-27 |
Talley; John J. |
Substituted isoxazoles for the treatment of inflammation
|
|
IL117580A0
(en)
|
1995-03-29 |
1996-07-23 |
Merck & Co Inc |
Inhibitors of farnesyl-protein transferase and pharmaceutical compositions containing them
|
|
DE69628559T2
(de)
|
1995-04-07 |
2004-04-29 |
Schering Corp. |
Carbonyl-piperaznyl und piperidinyl derivate zur hemmung farnesyl protein transferase
|
|
UA57002C2
(uk)
|
1995-10-13 |
2003-06-16 |
Мерк Фросст Кенада Енд Ко./Мерк Фросст Кенада Енд Сі. |
Похідне (метилсульфоніл)феніл-2-(5н)-фуранону, фармацевтична композиція та спосіб лікування
|
|
FR2744450A1
(fr)
|
1996-02-02 |
1997-08-08 |
Pf Medicament |
Nouvelles naphtylpiperazines derivees de cycloazanes substitues, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments
|
|
ATE233743T1
(de)
|
1996-04-12 |
2003-03-15 |
Searle & Co |
N-((4-(5-methyl-3-phenylisoxazol-4- yl)phenyl)sulphonylpropylamid und sein natriumsalz als pro-pharmakon von cox-2 inhibitoren
|
|
US5880128A
(en)
|
1996-05-08 |
1999-03-09 |
Schering Corporation |
Carbonyl piperazinyl and piperidinyl compounds
|
|
IL127441A
(en)
|
1996-07-18 |
2003-02-12 |
Merck Frosst Canada Inc |
Substituted pyridines, pharmaceutical compositions comprising them and their use in the preparation of anti-inflammatory medicaments or as selective cyclooxygenase-2 inhibitors
|
|
AU4722197A
(en)
|
1996-10-22 |
1998-05-15 |
Daiichi Pharmaceutical Co., Ltd. |
Novel remedies for infectious diseases
|
|
GB9623283D0
(en)
|
1996-11-08 |
1997-01-08 |
Zeneca Ltd |
Heterocyclic derivatives
|
|
UA56197C2
(uk)
|
1996-11-08 |
2003-05-15 |
Зенека Лімітед |
Гетероциклічні похідні
|
|
WO1998054164A1
(en)
|
1997-05-30 |
1998-12-03 |
Takeda Chemical Industries, Ltd. |
Sulfonamide derivatives, their production and use
|
|
GB9715894D0
(en)
|
1997-07-29 |
1997-10-01 |
Zeneca Ltd |
Heterocyclic derivatives
|
|
CO4960662A1
(es)
|
1997-08-28 |
2000-09-25 |
Novartis Ag |
Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
|
|
DK1032575T3
(da)
|
1997-09-05 |
2003-10-20 |
Glaxo Group Ltd |
2,3-diaryl-pyrazol(1,5-b)pyridazinderivater, deres fremstilling og anvendelse som cyclooxygenase 2 (COX-2) inhibitor
|
|
TR200002182T2
(tr)
|
1998-01-27 |
2000-12-21 |
Aventis Pharmaceuticals Products Inc. |
İkame edilmiş aksozaherosayklil faktör xa inhibitörleri
|
|
MXPA01002173A
(es)
|
1998-08-28 |
2003-07-14 |
Scios Inc |
Inhibidores de p38-alfa cinasa.
|
|
US7223772B1
(en)
|
1998-11-03 |
2007-05-29 |
Smithkline Beecham Corporation |
Pyrazolopyridine derivatives as selective cox-2 inhibitors
|
|
CA2348740A1
(en)
|
1998-12-23 |
2000-07-06 |
Ruth R. Wexler |
Thrombin or factor xa inhibitors
|
|
AUPP818099A0
(en)
|
1999-01-14 |
1999-02-11 |
Fujisawa Pharmaceutical Co., Ltd. |
New n-containing heterocyclic compounds
|
|
ATE261444T1
(de)
|
1999-02-27 |
2004-03-15 |
Glaxo Group Ltd |
Pyrazolopyridine
|
|
GB9927844D0
(en)
|
1999-11-26 |
2000-01-26 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0003224D0
(en)
|
2000-02-11 |
2000-04-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
AU2001241927A1
(en)
|
2000-02-28 |
2001-09-12 |
Scios Inc. |
Inhibitors of p38-alpha kinase
|
|
WO2001066534A2
(en)
|
2000-03-09 |
2001-09-13 |
Abbott Laboratories |
Cyclic and bicyclic diamino histamine-3 receptor antagonists
|
|
WO2001076693A1
(en)
|
2000-04-10 |
2001-10-18 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
FR2812198B1
(fr)
|
2000-07-28 |
2008-07-18 |
Sod Conseils Rech Applic |
DERIVES D'AMIDINES INHIBITEURS DE PHOSPHATASES cdc25
|
|
GB0021494D0
(en)
|
2000-09-01 |
2000-10-18 |
Glaxo Group Ltd |
Chemical comkpounds
|
|
US6693099B2
(en)
|
2000-10-17 |
2004-02-17 |
The Procter & Gamble Company |
Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
|
|
EP1389204A4
(en)
|
2001-04-26 |
2005-03-23 |
Kolon Inc |
NEW SULPHONAMIDE DERIVATIVES, THEIR INTERMEDIATES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS
|
|
DE10155684A1
(de)
|
2001-11-13 |
2003-05-22 |
Bayer Ag |
Thiazolharnstoffe
|
|
EP1314733A1
(en)
|
2001-11-22 |
2003-05-28 |
Aventis Pharma Deutschland GmbH |
Indole-2-carboxamides as factor Xa inhibitors
|
|
FR2833261B1
(fr)
|
2001-12-06 |
2004-07-02 |
Yang Ji Chemical Company Ltd |
Nouveaux composes inhibiteurs specifiques de la phospholipase a2 secretee non pancreatique humaine du groupe ii
|
|
KR100464261B1
(ko)
|
2002-01-24 |
2005-01-03 |
주식회사 파나진 |
Ｐｎａ 올리고머를 합성하기 위한 신규한 단량체 및 그의제조방법
|
|
CN100445276C
(zh)
|
2002-03-13 |
2008-12-24 |
詹森药业有限公司 |
用作组蛋白去乙酰酶抑制剂的磺酰基衍生物
|
|
DE10217006A1
(de)
|
2002-04-16 |
2003-11-06 |
Merck Patent Gmbh |
Substituierte Indole
|
|
NZ535763A
(en)
|
2002-04-18 |
2007-06-29 |
Schering Corp |
(1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists
|
|
CN1181065C
(zh)
|
2002-05-08 |
2004-12-22 |
上海医药工业研究院 |
芳烷甲酰烷基哌嗪衍生物及其作为脑神经保护剂的应用
|
|
DE10319435B4
(de)
*
|
2003-04-25 |
2018-07-26 |
Whitecryption Corporation |
Verfahren zur Verarbeitung von Daten zum Schutz eines Softwareprogramms vor Rekonstruktion
|
|
GB0325956D0
(en)
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
|
CA2559285A1
(en)
|
2004-03-18 |
2005-09-29 |
Brigham And Women's Hospital, Inc. |
Methods for the treatment of synucleinopathies
|
|
SE0400850D0
(sv)
|
2004-03-30 |
2004-03-31 |
Astrazeneca Ab |
Novel Compounds
|
|
US20060035884A1
(en)
|
2004-05-20 |
2006-02-16 |
Elan Pharmaceuticals, Inc. |
N-cyclic sulfonamido inhibitors of gamma secretase
|
|
DE102004035672A1
(de)
|
2004-07-22 |
2006-03-30 |
Windmöller & Hölscher Kg |
Verkürzte Stapelbildung
|
|
BRPI0515500A
(pt)
|
2004-09-20 |
2008-07-29 |
Xenon Pharmaceuticals Inc |
derivados piridazina para inibição de estearoil-coa-desaturase
|
|
TW200630337A
(en)
|
2004-10-14 |
2006-09-01 |
Euro Celtique Sa |
Piperidinyl compounds and the use thereof
|
|
DE102005013967A1
(de)
|
2004-11-05 |
2006-10-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Bradykinin-B1-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
|
|
DE102004054053A1
(de)
|
2004-11-05 |
2006-05-11 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Bradykinin-B1-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
|
|
EP1866298A2
(en)
|
2005-03-31 |
2007-12-19 |
Takeda San Diego, Inc. |
Hydroxysteroid dehydrogenase inhibitors
|
|
GB0510139D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B1
|
|
EP1966132A2
(en)
|
2005-12-15 |
2008-09-10 |
Boehringer Ingelheim International Gmbh |
Compounds which modulate the cb2 receptor
|
|
US7879880B2
(en)
|
2005-12-21 |
2011-02-01 |
Schering Corporation |
Substituted aniline derivatives useful as histamine H3 antagonists
|
|
JP2009521444A
(ja)
|
2005-12-22 |
2009-06-04 |
メルク エンド カムパニー インコーポレーテッド |
カルシウムチャンネルブロッカーとなる置換ピペリジン
|
|
KR20080098490A
(ko)
|
2006-01-13 |
2008-11-10 |
파마시클릭스, 인코포레이티드 |
티로신 키나제 억제제 및 이의 용도
|
|
US20070259879A1
(en)
|
2006-03-06 |
2007-11-08 |
Trimeris, Inc. |
Piperazine and piperidine biaryl derivatives
|
|
US7524848B2
(en)
*
|
2006-03-23 |
2009-04-28 |
Amgen Inc. |
Diaza heterocyclic amide compounds and their uses
|
|
WO2007110449A1
(en)
|
2006-03-29 |
2007-10-04 |
Euro-Celtique S.A. |
Benzenesulfonamide compounds and their use
|
|
US8791264B2
(en)
|
2006-04-13 |
2014-07-29 |
Purdue Pharma L.P. |
Benzenesulfonamide compounds and their use as blockers of calcium channels
|
|
WO2007118854A1
(en)
|
2006-04-13 |
2007-10-25 |
Euro-Celtique S.A. |
Benzenesulfonamide compounds and the use thereof
|
|
EP2040698A4
(en)
|
2006-07-14 |
2011-08-10 |
Shionogi & Co |
OXIM CONNECTIONS AND ITS USE
|
|
WO2008024284A2
(en)
*
|
2006-08-21 |
2008-02-28 |
Merck & Co., Inc. |
Sulfonylated piperazines as cannabinoid-1 receptor modulators
|
|
US20110172230A1
(en)
|
2006-08-23 |
2011-07-14 |
Takahiro Ishii |
Urea compound or salt thereof
|
|
WO2008048914A1
(en)
|
2006-10-17 |
2008-04-24 |
Boehringer Ingelheim International Gmbh |
Polycyclic compounds which modulate the cb2 receptor
|
|
CA2673177A1
(en)
|
2006-12-18 |
2008-06-26 |
7Tm Pharma A/S |
Modulators of cb1 receptors
|
|
US7507736B2
(en)
|
2007-02-07 |
2009-03-24 |
Hoffmann-La Roche Inc. |
Indol-2-yl-piperazin-1-yl-methanone derivatives
|
|
US7648979B2
(en)
|
2007-02-07 |
2010-01-19 |
Hoffmann-La Roche Inc. |
5-amido-(1H-indol-2-yl)-piperazin-1-yl-methanone derivatives
|
|
WO2008124118A1
(en)
|
2007-04-09 |
2008-10-16 |
Purdue Pharma L.P. |
Benzenesulfonyl compounds and the use therof
|
|
US8563732B2
(en)
|
2007-05-31 |
2013-10-22 |
Shionogi & Co., Ltd. |
Oxyimino compounds and the use thereof
|
|
EP2164326A4
(en)
|
2007-05-31 |
2012-05-09 |
Euro Celtique Sa |
AMIDE COMPOUNDS AND USE THEREOF
|
|
WO2009040659A2
(en)
|
2007-09-28 |
2009-04-02 |
Purdue Pharma L.P. |
Benzenesulfonamide compounds and the use thereof
|
|
JP2010540629A
(ja)
|
2007-10-04 |
2010-12-24 |
メルク・シャープ・エンド・ドーム・コーポレイション |
カルシウムチャネル遮断薬としての置換アリールスルホン誘導体
|
|
GB0813142D0
(en)
*
|
2008-07-17 |
2008-08-27 |
Glaxo Group Ltd |
Novel compounds
|